Experimental Alzheimer’s disease drug hailed as a success

An experimental drug for Alzheimer’s disease has shown to slow down the rate of decline in memory and thinking in people with early stage of Alzheimer’s disease. This is being hailed as a “historic moment” for dementia treatment. The cognition level of Alzheimer’s patients who were given the drug, which has been developed by Eisai and Biogen, declined by 27 per cent less than the patients who were on a placebo treatment after a period of 18 months. This is a modest but very significant change in clinical outcome, first time a drug has been clearly shown to change the disease’s trajectory.

The study enrolled around 1,800 patients with early stage Alzheimer’s, and these patients were given twice-weekly infusions of the drug called lecanemab. The drug also showed to “reduce toxic plaques in the brain and slow patients’ memory decline and ability to perform day-to-day tasks”. About a fifth of enrolled patients experienced side effects that include brain swelling or brain bleeding which was visible on PET scans, with about 3 per cent of them experiencing symptomatic side effects.

Keep Reading

The results of this study provide boost to the “amyloid hypothesis”, that assumes that “sticky plaques seen in the brains of dementia patients play a role in damaging brain cells and causing cognitive decline”.

“This is a historic moment for dementia research, as this is the first phase 3 trial of an Alzheimer’s drug in a generation to successfully slow cognitive decline,” said Dr Susan Kohlhaas, the director of research at Alzheimer’s Research UK. “Many people feel Alzheimer’s is an inevitable part of ageing. This spells it out: if you intervene early you can make an impact on how people progress.”

Rob Howard, a professor of old age psychiatry at University College London (UCL), said, “This is an unambiguously statistically positive result and represents something of an historic moment when we see the first convincing modification of Alzheimer’s disease. God knows, we’ve waited long enough for this.”

EU Reporter

As vast is the European region, the more diverse are the developments and news that are to be known. I bring to table the news and political affairs from region to your screens.

Recent Posts

The Truth About St. Patrick: 10 Surprising Facts

People misunderstand the historical importance of Saint Patrick to Ireland even though he remains its patron saint. However legends multiply… Read More

March 17, 2025

Tragic Nightclub Fire in North Macedonia: 59 Dead, Over 100 Injured

Today in the early morning a fire broke out at the Pulse nightclub in Kočani, North Macedonia. This led to… Read More

March 16, 2025

Texas Wildfire Update: Progress Made, Evacuations in Place at Fredericksburg

Firefighters are fighting against a massive grass fire north of Fredericksburg, Texas. The fire, which had started on Saturday afternoon… Read More

March 16, 2025

Trump Slashes Funding for Voice of America in Federal Agency Overhaul

On Friday President Donald Trump used his executive authority to order big budget reductions at seven government agencies including Voice… Read More

March 15, 2025

Trump’s Travel Ban Returns? 41 Nations Face Visa Suspensions

According to an internal memo reported by Reuters now Trump administration is considering new travel restrictions on citizens from 41… Read More

March 15, 2025

US Confirms Death of ISIS No. 2 Abu Khadijah in Iraq Airstrike

In a major counterterrorism operation the United States in coordination with Iraqi security forces, has confirmed the killing of Abu… Read More

March 15, 2025

This website uses cookies.

Read More